Free Trial

Ritholtz Wealth Management Invests $285,000 in Plexus Corp. (NASDAQ:PLXS)

Plexus logo with Computer and Technology background

Ritholtz Wealth Management purchased a new stake in Plexus Corp. (NASDAQ:PLXS - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 2,221 shares of the technology company's stock, valued at approximately $285,000.

A number of other institutional investors have also recently bought and sold shares of the stock. Nomura Asset Management Co. Ltd. boosted its holdings in shares of Plexus by 45.5% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 320 shares of the technology company's stock worth $50,000 after buying an additional 100 shares during the period. Tocqueville Asset Management L.P. grew its position in Plexus by 1.8% during the 4th quarter. Tocqueville Asset Management L.P. now owns 5,907 shares of the technology company's stock worth $924,000 after purchasing an additional 107 shares in the last quarter. Aquatic Capital Management LLC raised its stake in Plexus by 134.0% during the 4th quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock valued at $37,000 after purchasing an additional 134 shares during the period. Squarepoint Ops LLC lifted its holdings in shares of Plexus by 1.1% in the fourth quarter. Squarepoint Ops LLC now owns 13,846 shares of the technology company's stock valued at $2,167,000 after purchasing an additional 148 shares in the last quarter. Finally, TD Private Client Wealth LLC purchased a new stake in shares of Plexus in the fourth quarter valued at $28,000. Hedge funds and other institutional investors own 94.45% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. Needham & Company LLC reissued a "buy" rating and set a $162.00 price target (down from $172.00) on shares of Plexus in a research report on Friday, April 25th. Wall Street Zen raised shares of Plexus from a "buy" rating to a "strong-buy" rating in a research report on Saturday, June 14th. Stifel Nicolaus set a $145.00 target price on Plexus in a research note on Thursday, April 24th. Finally, Benchmark restated a "buy" rating and set a $160.00 price target on shares of Plexus in a research note on Wednesday, June 4th. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, Plexus presently has a consensus rating of "Moderate Buy" and an average price target of $155.67.

Get Our Latest Stock Report on Plexus

Insider Activity

In other news, Director Karen Marie Rapp sold 500 shares of the company's stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $130.77, for a total transaction of $65,385.00. Following the transaction, the director now directly owns 9,365 shares in the company, valued at approximately $1,224,661.05. This represents a 5.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Patrick John Jermain sold 4,328 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $132.29, for a total transaction of $572,551.12. Following the completion of the sale, the chief financial officer now directly owns 25,637 shares of the company's stock, valued at approximately $3,391,518.73. This represents a 14.44% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 12,032 shares of company stock worth $1,582,222. Company insiders own 1.76% of the company's stock.

Plexus Stock Performance

Shares of NASDAQ PLXS opened at $130.71 on Friday. Plexus Corp. has a 12 month low of $100.96 and a 12 month high of $172.89. The business's 50 day moving average is $128.96 and its two-hundred day moving average is $138.44. The company has a market cap of $3.54 billion, a P/E ratio of 25.43 and a beta of 0.81. The company has a quick ratio of 0.71, a current ratio of 1.53 and a debt-to-equity ratio of 0.07.

Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The technology company reported $1.66 EPS for the quarter, topping analysts' consensus estimates of $1.54 by $0.12. Plexus had a return on equity of 11.17% and a net margin of 3.60%. The company had revenue of $980.17 million during the quarter, compared to the consensus estimate of $980.07 million. During the same quarter last year, the company earned $0.94 EPS. The company's quarterly revenue was up 1.4% on a year-over-year basis. On average, equities analysts expect that Plexus Corp. will post 5.9 EPS for the current year.

About Plexus

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Featured Stories

Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS - Free Report).

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines